News
-
-
-
COMMUNIQUÉ DE PRESSE
SLS Europe and Bilthoven Biologicals receive positive CHMP Opinion for SIILTIBCY – a novel Tuberculosis Skin Test in Europe
SLS Europe and Bilthoven Biologicals receive positive CHMP Opinion for SIILTIBCY - a novel Tuberculosis Skin Test in Europe, poised to be the first skin test accurately detecting TB in Europe, with final approval expected by end of 2024